The cytokine profile of OCD: pathophysiological insights

References

• Connor TJ, Leonard BE. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci. 1998;62(7):583–606.
   PubMed Web of Science ®Google Scholar
• Leonard BE. Changes in the immune system in depression and dementia: causal or co-incidental effects? Int J Dev Neurosci. 2001;19(3):305–312.
   Web of Science ®Google Scholar
• Hinze-Selch D, Pollmächer T. In vitro cytokine secretion in individuals with schizophrenia: results, confounding factors, and implications for further research. Brain Behav Immun. 2001;15(4):282–318.
   Web of Science ®Google Scholar
• Maes M, Lin AH, Delmeire L, et al. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry. 1999;45(7):833–839.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Bellodi L, Perna G. Plasma levels of tumor necrosis factor-α in patients with panic disorder: effect of alprazolam therapy. Psychiatry Res. 1999;89(1):21–27.
   Web of Science ®Google Scholar
• Rapaport MH, Stein MB. Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobia. Anxiety. 1994;1(2):50–53.
   Google Scholar
• Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155(2):264–271.
   Google Scholar
• Dinn WM, Harris CL, McGonigal KM, Raynard RC. Obsessive-compulsive disorder and immunocompetence. Int J Psychiatry Med. 2001;31(3):311–320.
   Web of Science ®Google Scholar
• Murphy TK, Sajid MW, Goodman WK. Immunology of obsessive-compulsive disorder. Psychiatr Clin North Am. 2006;29(2):445–469.
   PubMed Web of Science ®Google Scholar
• Placidi GP, Boldrini M, Patronelli A, et al. Prevalence of psychiatric disorders in thyroid diseased patients. Neuropsychobiology. 1998; 38(4):222–225.
   PubMed Web of Science ®Google Scholar
• George MS, Kellner CH, Fossey MD. Obsessive-compulsive symptoms in a patient with multiple sclerosis. J Nerv Ment Dis. 1989;177(5):304–305.
   Web of Science ®Google Scholar
• Miguel EC, Stein MC, Rauch SL, O’Sullivan, Stern TA, Jenike MA. Obsessive-compulsive disorder in patients with multiple sclerosis. J Neuropsychiatry Clin Neurosci. 1995;7(4):507–510.
   Web of Science ®Google Scholar
• Maes M, Meltzer HY, Bosmans E. Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations. Neuropsychobiology. 1994;30(2–3):57–60.
   Web of Science ®Google Scholar
• Weizman R, Laor N, Barber Y, et al. Cytokine production in obsessive-compulsive disorder. Biol Psychiatry. 1996;40(9):908–912.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Perna G, Bellodi L, et al. Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol Psychiatry. 1997;42(11):976–981.
   Web of Science ®Google Scholar
• Konuk N, Tekin IO, Ozturk U, et al. Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediators Inflamm. 2007;2007:65704.
   Web of Science ®Google Scholar
• Marazziti D, Dell’Osso L. Why have early investigational therapies of obsessive-compulsive disorder failed to materialise? Expert Opin Investig Drugs. 2015;24(4):455–458.
   PubMed Web of Science ®Google Scholar
• Westenberg HG, Fineberg NA, Denys D. Neurobiology of obsessive–compulsive disorder: serotonin and beyond. CNS Spectr. 2007;12:14–27.
   Web of Science ®Google Scholar
• Marazziti D, Consoli G, Masala I, Catena Dell’Osso M, Baroni S. Latest advancements on serotonin and dopamine transporters in lymphocytes. Mini Rev Med Chem. 2010;10(1):32–40.
   Web of Science ®Google Scholar
• Lestage J, Verrier D, Palin K, Dantzer R. The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav Immun. 2002;16(5):596–601.
   PubMed Web of Science ®Google Scholar
• Kohl C, Sperner-Unterweger B. IDO and clinical conditions associated with depressive symptoms. Curr Drug Metab. 2007;8(3):283–287.
   Web of Science ®Google Scholar
• Marazziti D, Baroni S, Picchetti M, Piccinni A, Silvestri S, Dell’Osso L. New developments on the serotonin hypothesis of depression: shunt of tryptophan. Riv Psichiatr. 2013;48(1):23–34.
   Web of Science ®Google Scholar
• Fluitman S, Denys D, Vulink N, Schutters S, Heiknen C, Westenberg H. Lipopolysaccharide-induced cytokine production in obsessive-compulsive disorder and generalized social anxiety disorder. Psychiatry Res. 2010;178(2):313–316.
   Web of Science ®Google Scholar
• Baganz NL, Blakely RD. A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci. 2013;4(1):48–63.
   PubMed Web of Science ®Google Scholar
• Cappi C, Muniz RK, Sampaio AS, et al. Association study between functional polymorphisms in the TNF-α gene and obsessive-compulsive disorder. Arq Neuropsiquiatr. 2012;70(2):87–90.
   Web of Science ®Google Scholar
• Zacharko RM, Zalcman S, Macneil G, Andrews M, Mendella PD, Anisman H. Differential effects of immunologic challenge on self-stimulation from the nucleus accumbens and the substantia nigra. Pharmacol Biochem Behav. 1997;58(4):881–886.
   Web of Science ®Google Scholar
• Devoino LV, Al’perina EL, Gevorgyan MM, Cheido MA. Involvement of dopamine D1 and D2 receptors in the rat nucleus accumbens in immunostimulation. Neurosci Behav Physiol. 2007;37(2):147–151.
   Google Scholar
• Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L. Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates β1 integrin function. Eur J Immunol. 2001;31(12):3504–3512.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Nakayama T, Nagakubo D, et al. Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. J Immunol. 2006;176(2):848–856.
   PubMed Web of Science ®Google Scholar
• Sarkar C, Basu B, Chakroborty D, et al. The immunoregulatory role of dopamine: an update. Brain Behav Immun. 2010;249:525–528.
   Google Scholar
• Besser MJ, Ganor Y, Levite M. Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNF-α or both. J Neuroimmunol. 2005;169(1–2):161–171.
   PubMed Web of Science ®Google Scholar
• Cosentino M, Fietta AM, Ferrari M, et al. Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood. 2007;109(2):632–642.
   PubMed Web of Science ®Google Scholar
• Catapano F, Monteleone P, Fuschino A, Maj M, Kemali D. Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder. Psychiatry Res. 1992;44(3):217–225.
   PubMed Web of Science ®Google Scholar
• Monteleone P, Catapano F, Tortorella A, Di Martino S, Maj M. Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment. Psychoneuroendocrinology. 1995;20(7):763–770.
   PubMed Web of Science ®Google Scholar
• Kluge M, Schüssler P, Künzel HE, Dresler M, Yassouridis A, Steiger A. Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. J Psychiatr Res. 2007;41(11):928–933.
   PubMed Web of Science ®Google Scholar
• Bastani B, Nash JF, Meltzer HY. Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder. Arch Gen Psychiatry. 1990;47(9):833–839.
   Web of Science ®Google Scholar
• Millet B, Touitou Y, Poirier MF, et al. Plasma melatonin and cortisol in patients with obsessive-compulsive disorder: relationship with axillary temperature, physical activity, and clinical symptoms. Biol Psychiatry. 1998;44(9):874–881.
   Web of Science ®Google Scholar
• Weizman R, Gil-Ad I, Hermesh H, Munitz H, Laron Z. Immunoreactive β-endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorder. Clin Neuropharmacol. 1990;13(4):297–302.
   Web of Science ®Google Scholar
• Fluitman SB, Denys DA, Heijnen CJ, Westenberg HG. Disgust affects TNF-α, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder. Psychoneuroendocrinology. 2010;35(6):906–911.
   PubMed Web of Science ®Google Scholar
• Denys D, Fluitman S, Kavelaars A, Heijnen CJ, Westenberg HG. Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive-compulsive disorder. Psychoneuroendocrinology. 2006; 31(3):355–360.
   PubMed Web of Science ®Google Scholar
• Hounie AG, Cappi C, Cordeiro Q, et al. TNF-α polymorphisms are associated with obsessive-compulsive disorder. Neurosci Lett. 2008; 442(2):86–90.
   Web of Science ®Google Scholar
• Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med. 2002;156(4):356–361.
   PubMedGoogle Scholar
• Kawikova I, Leckman JF, Kronig H, et al. Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: a preliminary study. Biol Psychiatry. 2007;61(3):273–278.
   PubMed Web of Science ®Google Scholar
• Sayyah M, Boostani H, Pakseresht S, Malayeri A. A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder. Psychiatry Res. 2011;189(3):403–406.
   PubMed Web of Science ®Google Scholar
• Marazziti D, Presta S, Pfanner C, et al. Immunological alterations in adult obsessive-compulsive disorder. Biol Psychiatry. 1999;46(6):810–814.
   Web of Science ®Google Scholar
• Denys D, Fluitman S, Kavelaars A, Heijnen CJ, Westenberg HG. Decreased TNF-α and NK activity in obsessive-compulsive disorder. Psychoneuroendocrinology. 2004;29(7):945–952.
   PubMed Web of Science ®Google Scholar
• Ravindran AV, Griffiths J, Merali Z, Ansiman H. Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls. J Affect Disord. 1999;52(1–3):1–10.
   Web of Science ®Google Scholar
• Dale RC. Post-streptococcal autoimmune disorders of the central nervous system. Dev Med Child Neurol. 2005;47(11):785–791.
   Web of Science ®Google Scholar
• Hounie AG, Pauls DL, do Rosario-Campos MC, et al. Obsessive-compulsive spectrum disorders and rheumatic fever: a family study. Biol Psychiatry. 2007;61(3):266–272.
   Web of Science ®Google Scholar
• Seixas AA, Hounie AG, Fossaluza V, et al. Anxiety disorders and rheumatic fever: is there an association? CNS Spectr. 2008;13(12):1039–1046.
   Web of Science ®Google Scholar
• Ramasawmy R, Faé KC, Spina G, et al. Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. Mol Immunol. 2007;44(8):1873–1878.
   PubMed Web of Science ®Google Scholar
• Teixeira AL, Rodrigues DH, Marques AH, Miguel EC, Fontenelle LF. Searching for the immune basis of obsessive-compulsive disorder. Neuroimmunomodulation. 2014;21(2–3):152–158.
   PubMed Web of Science ®Google Scholar
• Swedo SE. Sydenham’s chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA. 1994;272(22):1788–1791.
   PubMed Web of Science ®Google Scholar
• Asbahr FR, Negrao AB, Gentil V, et al. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry. 1998;155(8):1122–1124.
   Web of Science ®Google Scholar
• Mercadante MT, Busatto GF, Lombroso PJ, et al. The psychiatric symptoms of rheumatic fever. Am J Psychiatry. 2000;157(12):2036–2038.
   PubMed Web of Science ®Google Scholar
• Swedo SE, Leonard HL, Mittleman BB, et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry. 1997;154(1):110–112.
   PubMed Web of Science ®Google Scholar
• Kurlan R. Tourette’s syndrome and ‘PANDAS’. Will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Neurology. 1998;50(6):1530–1534.
   Google Scholar
• Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet. 1999;354(9185):1153–1158.
   PubMed Web of Science ®Google Scholar
• Singer HS, Giuliano JD, Hansen BH, et al. Antibodies against human putamen in children with Tourette syndrome. Neurology. 1998;50(6):1618–1624.
   PubMed Web of Science ®Google Scholar
• Murphy TK, Sajid M, Soto O, et al. Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biol Psychiatry. 2004;55(1):61–68.
   Web of Science ®Google Scholar
• Allen AJ, Leonard HL, Swedo SE. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette’s syndrome. J Am Acad Child Adolesc Psychiatry. 1995;34(3):307–311.
   PubMed Web of Science ®Google Scholar
• Fallon BA, Nields JA. Lyme disease: a neuropsychiatric illness. Am J Psychiatry. 1994;151(11):1571–1583.
   PubMed Web of Science ®Google Scholar
• Mell LK, Davis RL, Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette’s syndrome, and tic disorder. Pediatrics. 2005;116(1):56–60.
   Web of Science ®Google Scholar
• Balkwill FR, Burke F. The cytokine network. Immunol Today. 1989;10(9):299–304.
   PubMedGoogle Scholar
• Luger TA, Schwarz T. Evidence for an epidermal cytokine network. J Invest Dermatol. 1990;95(Suppl 6):100S–104S.
   Web of Science ®Google Scholar
• Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol. 2003;25(2):115–121.
   PubMed Web of Science ®Google Scholar
• Haddy N, Sass C, Maumus S, et al. Biological variations, genetic polymorphisms and familial resemblance of TNF-α and IL-6 concentrations: STANISLAS cohort. Eur J Hum Genet. 2005;13(1):109–117.
   PubMed Web of Science ®Google Scholar
• Monteleone P, Catapano F, Fabrazzo M, Tortorella A, Maj M. Decreased blood levels of tumor necrosis factor alpha in patients with obsessive-compulsive disorder. Neuropsychobiology. 1998;37(4):182–185.
   PubMed Web of Science ®Google Scholar
• Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19(1):11–38.
   PubMed Web of Science ®Google Scholar
• Hopkins SJ, Rothwell NJ. Cytokines and the nervous system I: expression and recognition. Trends Neurosci. 1995;18(2):83–88.
   PubMed Web of Science ®Google Scholar
• Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 1995;18(3):130–136.
   PubMed Web of Science ®Google Scholar
• Fiore M, Alleva E, Probert L, Kollias G, Angelucci F, Aloe L. Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-α. Physiol Behav. 1998;63(4):571–576.
   PubMed Web of Science ®Google Scholar
• Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev. 1998;105(1):83–107.
   PubMed Web of Science ®Google Scholar
• Albensi BC, Mattson MP. Evidence for the involvement of TNF and NF-κB in hippocampal synaptic plasticity. Synapse. 2000;35(2):151–159.
   PubMed Web of Science ®Google Scholar
• Pickering M, O’Connor JJ. Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog Brain Res. 2007;163:339–354.
   PubMed Web of Science ®Google Scholar
• Muller J, Roberts JE. Memory and attention in obsessive-compulsive disorder: a review. J Anxiety Disord. 2005;19(1):1–28.
   PubMed Web of Science ®Google Scholar
• Cavedini P, Gorini A, Bellodi L. Understanding obsessive-compulsive disorder: focus on decision making. Neuropsychol. Rev. 2006;16(1):3–15.
   Web of Science ®Google Scholar
• De Geus GF, Denys DA, Sitskoorn MM, Westenberg HG. Attention and cognition in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci. 2007;61(1):45–53.
   PubMed Web of Science ®Google Scholar
• Hong SB, Shin YW, Kim SH, et al. Hippocampal shape deformity analysis in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci. 2007;257(4):185–190.
   Web of Science ®Google Scholar
• Rauch SL, Wedig MM, Wright CI. Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol Psychiatry. 2007;61(3):330–336.
   PubMed Web of Science ®Google Scholar
• Balschun D, Wetzel W, Del Rey A. Interleukin-6, a cytokine to forget. Faseb J. 2004;18(14):1788–1790.
   PubMedGoogle Scholar
• McCoy M, Tansey M. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflamm. 2008;5(45):1–13.
   Google Scholar
• Murphy K, Travers P, Walport M. Janeway’s Immunobiology. 7th ed. New York, NY: Garland Science; 2008.
   Google Scholar
• Gray SM, Bloch MH. Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Curr Psychiatry Rep. 2012;14(3):220–228.
   PubMed Web of Science ®Google Scholar
• Himmerich H, Berthold-Losleben M, Pollmacher T. The relevance of the TNF-α system in psychiatric disorders. Fortschr Neurol Psychiatr. 2009;77(6):334–345.
   Web of Science ®Google Scholar
• Hanna GL, Veenstra-VanderWeele J, Cox NJ, et al. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet. 2002;114(5):541–552.
   PubMed Web of Science ®Google Scholar
• De Mathis MA, Diniz JB, Shavitt RG, et al. Early onset obsessive-compulsive disorder with and without tics. CNS Spectr. 2009;14(7):362–370.
   Web of Science ®Google Scholar
• Tukel R, Ertekin E, Batmaz S, et al. Influence of age of onset on clinical features in obsessive-compulsive disorder. Depress Anxiety. 2005;21(3):112–117.
   PubMed Web of Science ®Google Scholar
• Lochner C, Hemmings SM, Kinnear CJ, et al. Cluster analysis of obsessive-compulsive symptomatology: identifying obsessive-compulsive disorder subtypes. Isr J Psychiatry Relat Sci. 2008;45(3):164–176.
   Web of Science ®Google Scholar
• Matsunaga H, Maebayashi K, Hayashida K, et al. Symptom structure in Japanese patients with obsessive compulsive disorder. Am J Psychiatry. 2008;165(2):251–253.
   Web of Science ®Google Scholar
• Rosario-Campos MC, Leckman JF, Mercadante MT, et al. Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry. 2001;158(11):1899–1903.
   PubMed Web of Science ®Google Scholar
• Leckman JF, Katsovich L, Kawikova I, et al. Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette’s syndrome. Biol Psychiatry. 2005;57(6):667–673.
   Web of Science ®Google Scholar
• Barbosa IG, Huguet RB, Mendonca VA, et al. Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2011;261(2):139–143.
   PubMed Web of Science ®Google Scholar
• Scalzo P, Kummer A, Cardoso F, Teixeira AL. Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson’s disease. J Neuroimmunol. 2009;216(1–2):122–125.
   Web of Science ®Google Scholar
• Fontenelle LF, Barbosa IG, Luna JV, de Sousa LP, Abreu MN, Teixeira AL. A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry. 2012;53(6):797–804.
   PubMed Web of Science ®Google Scholar
• Zúniga J, Vargas-Alarcón G, Hernández-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun. 2001;2(7):363–366.
   Web of Science ®Google Scholar
• Kroeger KM, Carville KS, Abraham LJ. The-308 tumor necrosis factor alpha promoter polymorphism effects transcription. Mol Immunol. 1997;34(5):391–399.
   PubMed Web of Science ®Google Scholar
• Sallakci N, Akcurin G, Koksoy S, et al. TNF-α G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-α production. J Autoimmun. 2005;25(2):150–154.
   PubMed Web of Science ®Google Scholar
• Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A. Genetic influence on cytokine production in meningococcal disease. Lancet. 1997;349(9069):1912–1913.
   Web of Science ®Google Scholar
• Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNF alpha)−308 promoter polymorphism in TNF-α gene regulation. J Inflamm. 1995; 46(1):32–41.
   PubMedGoogle Scholar
• Uglialoro AM, Turbay D, Pesavento PA, et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-gene promoter. Tissue Antigens. 1998;52(4):359–367.
   PubMed Web of Science ®Google Scholar
• Fong CL, Siddiqui AH, Mark DF. Identification and characterization of a novel repressor site in the human tumor necrosis factor alpha gene. Nucl Acids Res. 1994;22(6):1108–1114.
   Web of Science ®Google Scholar
• Bayley JP, De Rooij H, Van Den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the −376, −308, −244, and −238 polymorphic sites of the TNF-alpha promoter. Cytokine. 2001;14(6):316–323.
   Web of Science ®Google Scholar
• Drouet C, Shakhov AN, Jongeneel CV. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. J Immunol. 1991;147(5):1694–1700.
   Web of Science ®Google Scholar
• Pociot F, D’Alfonso S, Compasso S, Scorz R, Richiardi PM. Functional analysis of a new polymorphism in the human TNF-α gene promoter. Scand J Immunol. 1995;42(4):501–504.
   Web of Science ®Google Scholar
• Kaluza W, Reuss E, Grossmann S. Different transcriptional activity and in vitro TNF-α production in psoriasis patients carrying the TNF-α 238A promoter polymorphism. J Invest Dermatol. 2000;114(6):1180–1183.
   PubMed Web of Science ®Google Scholar
• Dowlaty Y, Hermann N, Swardfager W, Liu H, et al.: A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010; 67:446–457.
   Web of Science ®Google Scholar
• Sawada M, Imamura K, Nagatsu T. Role of cytokines in inflammatory process in Parkinson’s disease. J Neural Transm. 2006; 70(Suppl):373–381.
   Google Scholar
• Kishimoto T. Interleukin-6 and its receptor in autoimmunity. J Autoimmun. 1992;5(1 Suppl A):123–132.
   Google Scholar
• Spooren A, Kolmus K, Laureys G, et al. Interleukin-6, a mental cytokine. Brain Res Rev. 2011;67(1–2):157–183.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–550.
   PubMed Web of Science ®Google Scholar
• Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen1 (LFA-1). Cell. 1987;51:813–819.
   PubMed Web of Science ®Google Scholar
• Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986;137(1):245–254.
   PubMed Web of Science ®Google Scholar
• Sironi M, Breviario F, Proserpio P, et al. IL-1 stimulates IL-6 production in endothelial cells. J Immunol. 1989;142(2):549–553.
   PubMed Web of Science ®Google Scholar
• Wang CC, Fu CL, Yang YH, et al. Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma. Gene Ther. 2006;13(19):1414–1421.
   Web of Science ®Google Scholar
• Nakae S, Asano M, Horai R, Iwakura Y. Interleukin-1β, but not interleukin-1α, is required for T-cell dependent antibody production. Immunology. 2001;104:402–409.
   Web of Science ®Google Scholar
• Zheng H, Fletcher D, Kozak W, et al. Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice. Immunity. 1995;3(1):9–19.
   Web of Science ®Google Scholar
• Marazziti D, Perez J, Cassano GB. Is obsessive-compulsive disorder caused by a second messenger imbalance? CNS Spectr. 2001;6(3):206–209.
   Google Scholar
• Marazziti D, Baroni S, Palego L, et al. Adenylate-cyclase activity in platelets of patients with obsessive-compulsive disorder. Neuropsychiatr Dis Treat. 2009;5:363–367.
   Web of Science ®Google Scholar
• Fitzgerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001;345(6):433–442.
   PubMed Web of Science ®Google Scholar
• Akhondzadeh S, Jafari S, Raisi F, et al. Clinical trial of adjunctive cleecoxib treatment in patients with major depressive: a double blind and placebo controlled trial. Depress Anxiety. 2009;26(7):607–611.
   PubMed Web of Science ®Google Scholar
• Ohishi K, Ueno R, Nishino S, Sakai T, Hayaishi O. Increased level of salivary prostaglandins in patients with major depression. Biol Psychiatry. 1988;23(4):326–334.
   PubMed Web of Science ®Google Scholar
• Frommberger UH, Bauer J, Haselbauer P, Fräulin A, Riemann D, Berger M. Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci. 1997;247(4):228–233.
   PubMed Web of Science ®Google Scholar
• Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaegh E, Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997;9(11):853–858.
   PubMed Web of Science ®Google Scholar
• Marazziti D, Mungai F, Masala I, et al. Normalisation of immune cell imbalance after pharmacological treatments of patients suffering from obsessive-compulsive disorder. J Psychopharmacol. 2009;23(5):567–573.
   PubMed Web of Science ®Google Scholar